CLEC12A and experimental autoimmune encephalomyelitis: MICL also recognizes an unknown ligand on endothelial cells which facilitates the binding and transmigration of DCs across the blood–brain barrier, and both antibody targeting and the genetic deletion of MICL protect animals in a mouse model of experimental autoimmune encephalomyelitis (Sagar et al, 2017).